Betrixaban (trade name Bevyxxa) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Betrixaban is FDA approved for venous thrombosis...
9 KB (704 words) - 06:20, 9 February 2024
inhibitor (dabigatran) and factor Xa inhibitor (rivaroxaban, apixaban, betrixaban and edoxaban), and they have been shown to be as good or possibly better...
78 KB (8,726 words) - 15:18, 29 April 2024
the authorisation (approved) Andexanet for the 28 countries of the EU. Betrixaban (Bevyxxa), an oral direct FXa inhibitor for prevention of thrombosis;...
8 KB (634 words) - 19:42, 27 February 2024
etexilate B01AF01 Rivaroxaban B01AF02 Apixaban B01AF03 Edoxaban B01AF04 Betrixaban B01AF51 Rivaroxaban and acetylsalicylic acid B01AX01 Defibrotide B01AX04...
3 KB (346 words) - 19:19, 12 March 2024
(Eliquis) from Bristol-Myers Squibb, edoxaban (Lixiana) from Daiichi, and betrixaban (Bevyxxa) from Portola Pharmaceuticals. Xabans that never reached the...
16 KB (1,525 words) - 03:57, 3 February 2024
Xa has been developed. These include the drugs rivaroxaban, apixaban, betrixaban, LY517717, darexaban (YM150), edoxaban and 813893. These agents have several...
27 KB (3,337 words) - 10:35, 11 May 2024
Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. Betrixaban (Bevyxxa) was approved in the US in 2017. Heparin was discovered by Jay...
41 KB (4,917 words) - 22:24, 10 May 2024
Betimol Betnesol Betnovate Betoptic Pilo Betoptic S betoxycaine (INN) betrixaban (USAN) bevacizumab (INN) bevacizumab gamma (INN) bevantolol (INN) bevasiranib...
14 KB (619 words) - 06:39, 1 June 2024